New patent for Neurocrine drug ONGENTYS
Annual Drug Patent Expirations for ONGENTYS Ongentys is a drug marketed by Neurocrine and is included in one NDA. It is available from two suppliers. There are nine patents protecting…
Source
Get email updates
Get new actionable insights and updates from BiotechBlog